Dr. Chalasani is considered an authority in the fields of Non-Alcoholic Fatty Liver Disease (NAFLD) and Drug Induced Liver Injury (DILI), two highly significant public health problems.

Research: Non-Alcoholic Fatty Liver Disease (NAFLD), Drug Hepatotoxicity, Drug Metabolism

Clinical Interests: Acute and chronic liver disease, Fatty Liver, Non-Alcoholic Steatohepatitis (NASH), Drug Hepatotoxicity, Drug Metabolism

An important portion of his research focuses on clinical and translational aspects of hepatocellular carcinoma, one of the leading causes of cancer death worldwide.

Research: Nutrition and Physiology of Diabetes and Obesity

Past Affiliations
Oncology, Gastroenterology, Gastroenterology
MD, Kakatiya Medical College, India, 1988
BS, Andhra Loyola College, India, Biology, 1981